The goal of our study was to assess whether the human immunodeficiency virus (HIV) coat protein gpl20 induces functional alterations in astrocytes and microglia, known for their reactivity and involvement in most types of brain pathology. We hypothesized that gpl20-induced anomalies in glial functions, ifpresent, might be mediated by changes in the levels of intracellular messengers important for signal transduction, such as cAMP. Acute (10 min) exposure of cultured rat cortical astrocytes or microglia to 100 pM gpl20 caused only a modest (50-60%), though statistically significant, elevation in cAMP levels, which was antagonized by the (3-adrenergic receptor antagonist propranolol. More importantly, the protein substantially depressed [by 30% (astrocytes) and 50% (microglia)] the large increase in cAMP induced by the .3-adrenergic agonist isoproterenol (10 nM), without affecting that induced by direct adenylate cyclase stimulation by forskolin. Qualitatively similar results were obtained using a glial fibrillary acidic protein (GFAP)-positive human glioma cell line. The depression of the (3-adrenergic response had functional consequences in both astrocytes and microglia. In astrocytes we studied the phosphorylation of the two major cytoskeletal proteins, vimentin and GFAP, which is normally stimulated by isoproterenol, and found that gpl20 partially (40-50%) prevented such stimulation. In microglial cells, which are the major producers of inflammatory cytokines within the brain, gpl20 partially antagonized the negative ,3-adrenergic modulation of lipopolysaccharide (10 ng/ml)-induced production of tumor necrosis factor a. Our results suggest that, by interfering with the ,B-adrenergic regulation of astrocytes and microglia, gpl20 may alter astroglial "reactivity" and upset the delicate cytokine network responsible for the defense against viral and opportunistic infections.The pathogenesis of AIDS encephalopathy, a complication present in 50-80% of AIDS patients, is still largely unknown (1-4). Besides direct infection of brain cells by human immunodeficiency virus (HIV), which seems to occur mainly in microglia (2-6), the intrinsic brain macrophages, other factors could contribute to the development of brain damage, such as neurotoxic substances produced by brain cells and/or by invading hematic cells, or proteins encoded by the viral genome. Among the latter, the envelope glycoprotein gp120 was reported to cause neuronal death in cell cultures from the rodent central nervous system (reviewed in ref. 7; see also ref. 8) and to induce interleukin 1 (9) and to cause learning impairment (10) in the rat brain in vivo. In the present study we evaluated the possibility that the viral protein may cause functional alterations in glial cell types (astrocytes and microglia) known for their reactivity and involvement in most neurological diseases. We found that acute exposure to picomolar gp120 depressed the (3adrenergic agonist-induced formation of cAMP and altered important cAMP-regulated functions in both cel...